Ziprasidone in Pediatric Bipolar Disorder: a 6-Week, Open-Label Comparison of Rapid vs. Slow Dose Titration.
Phase of Trial: Phase IV
Latest Information Update: 23 Sep 2014
At a glance
- Drugs Ziprasidone (Primary)
- Indications Bipolar disorders
- Focus Therapeutic Use
- 13 Jan 2010 Actual patient number (45) added as reported by ClinicalTrials.gov.
- 13 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Mar 2008 New trial record.